Answers are grounded in this paper and cite their sources.
Explores health benefits of lycopene in nutraceuticals, suggesting enhanced bioavailability and production methods.
Lycopene (C 40 H 56 ), a carotenoid abundant in tomatoes, exhibits potent antioxidant, anti-inflammatory, anticancer, and cardioprotective properties. Its 11 conjugated double bonds confer superior singlet oxygen quenching activity with reduced prostate cancer and cardiovascular risks via modulation of NF-κB, IGF-1, MMP activities, and epigenetic pathways. Despite its therapeutic potential, clinical application is hindered by poor availability. Recent advances in delivery systems including nanoemulsions, smart carriers, and 3D-printed nutraceuticals enhance stability and targeted absorption. Concurrently, production is shifting toward sustainable methods like supercritical CO 2 and microbial biosynthesis using engineered E. coli and Yarrowia lipolytica , further optimized by AI-assisted fermentation and omics-based tools. While lycopene holds GRAS-certified (FDA) and E160d (EU) status, regulatory inconsistencies and limited clinical substantiation of health claims remain. Future research should emphasize systems biology, genotype-specific trials, and harmonized regulations to unlock lycopene's potential in precision health and nutraceutical innovation. • Lycopene shows high potential in precision health advantages • Its 11 double bonds give the highest singlet oxygen quenching among carotenoids • Nanoformulation greatly improve lycopene stability, absorption and bioavailability • Green extraction and microbial biosynthesis boost sustainable lycopene production • Future work needs systems biology, genotype-specific trials and clearer regulations
No takes yet. Share an insight, caveat, or question.
Benabdelmoumene et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: